ClinConnect ClinConnect Logo
Search / Trial NCT05461495

NYUCI-ES: Psychosocial Intervention to Improve Health Outcomes for Chinese and Korean ADRD Caregivers

Launched by NEW YORK UNIVERSITY · Jul 13, 2022

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Dementia Caregivers Social Support Depressive Symptoms Physical Health Chinese American Korean American

ClinConnect Summary

This clinical trial, called the NYUCI-ES, is studying how a special support program can help Chinese and Korean American caregivers who are taking care of family members with dementia. The program includes online chat groups and culturally relevant materials to better support these caregivers. Researchers want to see if this program can reduce feelings of depression and stress, improve overall health, and lower risks for conditions like diabetes and heart disease over the course of a year.

To participate in this study, you need to be a primary caregiver of Chinese or Korean descent, at least 50 years old, and living in New York City or Bergen County, New Jersey. You should be comfortable using the internet and reading in English, Chinese, or Korean. The study will include 300 caregivers, and you can expect to receive support through counseling and peer discussions, as well as educational resources about caregiving. This study aims to not only help improve your health but also to influence healthcare policies that can benefit caregivers from diverse backgrounds in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • A spouse or other family caregiver of Chinese or Korean ancestry living in New York City or Bergen County New Jersey, who is willing to participate in the study (additional family members can be included in family counseling sessions if the CG is assigned to the treatment group)
  • at least 50 years of age
  • self-identified as a primary caregiver
  • have access to Internet and phone with SMS and voice messaging
  • no plans to move for 12 months
  • able to read English, Chinese, or Korean
  • capable of completing informed consent
  • meet specific cardiometabolic and depressive symptom criteria: Cardiometabolic syndrome: It will not be required to submit objective measurement of cardiometabolic disorder, self-reported medical conditions will be accepted for enrollment. Diabetes: self-reported OR A1C \>= 5.7% OR High Cholesterol: self-reported OR low-density lipoprotein (LDL) \> 130 mg/dL or total cholesterol \> 200 mg/dL (American Heart Association 2018) OR Hypertension: self-reported OR systolic blood pressure (SBP) \>= 130 mmHg or diastolic blood pressure (DBP) \>= 80mmHg (2017 ACC/AHA hypertension guideline) OR Body Mass Index \> 23 kg/m2 by self-reported or measured height and weight (WHO expert consultation regarding Asian cut-off) OR other related metabolic syndrome, such as euthyroid hypothyroxinemia.
  • care recipient regularly has trouble remembering recent events, repeat the same question over and over, or lose or misplace things
  • Exclusion Criteria:
  • current alcoholic or substance abuse; and history of psychiatric diagnoses requiring hospitalization during the past 5 years.

About New York University

New York University (NYU) is a prestigious research institution renowned for its commitment to advancing medical knowledge and improving patient care through innovative clinical trials. With a robust infrastructure and a diverse team of leading experts, NYU conducts cutting-edge research across various therapeutic areas, focusing on translating scientific discoveries into effective treatments. The university fosters collaboration among multidisciplinary teams and engages with a broad patient population, ensuring that its trials adhere to the highest ethical standards and regulatory requirements. NYU's dedication to excellence in research and education positions it as a key contributor to the advancement of healthcare and clinical practice.

Locations

New York, New York, United States

Patients applied

0 patients applied

Trial Officials

Bei Wu, PhD

Principal Investigator

New York University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials